MAPT and Alzheimer disease: Notably, tau pathology induced by AD-tau seeding was significantly reduced in neurons treated with ASAP1 or FIP3 ASOs compared to those treated with PBS or scrambled control ASOs (Fig. 6e, f), suggesting the involvement of ASAP1 in tau seeding.